What is the recommended dose and duration of prednisone (corticosteroid) for treating Bell's palsy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prednisone Treatment for Bell's Palsy

Patients with Bell's palsy should be treated with oral prednisone at a dose of 60-80mg daily for 7 days followed by a gradual taper, and treatment should be initiated within 72 hours of symptom onset. 1

Dosing and Duration

  • Recommended regimen:
    • Prednisone 60-80mg daily for 7 days, followed by a gradual taper 1
    • Treatment must be initiated within 72 hours of symptom onset for maximum effectiveness 1

Evidence Supporting Corticosteroid Use

The American Academy of Otolaryngology-Head and Neck Surgery strongly recommends oral corticosteroids as the cornerstone of Bell's palsy treatment, with high-quality evidence demonstrating significant improvement in recovery rates from 70% to 94% 1.

Research supports this recommendation:

  • In a double-blind, placebo-controlled trial, patients treated with prednisolone had significantly higher recovery rates at 3 months (83.0%) compared to those not receiving prednisolone (63.6%) 2
  • The number needed to treat (NNT) to achieve one additional complete recovery was only 6 patients 3
  • At 9 months, recovery rates were 94.4% for prednisolone versus 81.6% for no prednisolone 3

Timing of Treatment

The timing of corticosteroid administration is crucial:

  • Patients treated within 24 hours had 66% complete recovery rate
  • Patients treated within 25-48 hours had 76% complete recovery rate
  • Both significantly better than patients not receiving prednisolone (51% and 58% respectively) 4
  • No significant benefit was observed when treatment was started after 48 hours 4

Dosage Considerations

While the standard recommended dose is 60-80mg daily, some research has explored higher doses:

  • A meta-analysis found that high-dose corticosteroids (initial prednisolone ≥100mg daily) were associated with decreased nonrecovery compared to standard doses (50-60mg) 5
  • However, this evidence is of very low quality, and the American Academy of Otolaryngology-Head and Neck Surgery guidelines still recommend the 60-80mg daily dose 1, 5

Antiviral Therapy

  • Antiviral therapy (such as acyclovir) is optionally recommended
  • Evidence shows minimal additional benefit when combined with steroids 1
  • Studies have not demonstrated significant improvement with acyclovir alone (71.2% recovery) versus no acyclovir (75.7% recovery) 2

Important Clinical Considerations

  • Mandatory eye protection is essential for patients with impaired eye closure 1
  • Use the House-Brackmann scale (grades 1-6) to quantify facial nerve function and monitor progress 1
  • Refer patients to a facial nerve specialist if:
    • Swallowing difficulties persist beyond 3 months
    • Incomplete facial recovery after 3 months
    • New or worsening neurological findings
    • Ocular symptoms develop 1

Common Pitfalls to Avoid

  1. Delayed treatment: Starting treatment after 48 hours significantly reduces effectiveness 4
  2. Inadequate eye protection: Patients with impaired eye closure require mandatory eye protection to prevent corneal damage 1
  3. Missing follow-up: Patients with incomplete recovery after 3 months should be referred to specialists 1
  4. Relying solely on antivirals: Antivirals alone have not shown significant benefit and should not replace corticosteroids 1, 2, 3

Early treatment with appropriate doses of prednisone significantly improves outcomes in Bell's palsy, with the greatest benefit seen when initiated within 48 hours of symptom onset.

References

Guideline

Bell's Palsy Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Early treatment with prednisolone or acyclovir in Bell's palsy.

The New England journal of medicine, 2007

Research

Prednisolone in Bell's palsy related to treatment start and age.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2011

Research

High-dose Corticosteroids for Adult Bell's Palsy: Systematic Review and Meta-analysis.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.